A binary histologic grading system for ovarian serous carcinoma is an independent prognostic factor: A population-based study of 4317 women diagnosed in Denmark 1978-2006

Gynecologic Oncology

Volumn 125, Issue 3, 2012, Pages 655-660

  Hannibal, Charlotte Gerd ^a   Vang, Russell ^b   Junge, Jette ^c   Kjaerbye Thygesen, Anette ^a   Kurman, Robert J ^b   Kjaer, Susanne K ^a,d  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HVIDOVRE HOSPITAL   (Denmark)

^d Rigshospitalet   (Denmark)

Author keywords

Binary grading system; Expert gynecologic pathology slide review; Ovarian serous carcinoma; Overall survival; Population based; Registry based

Indexed keywords

ADULT; AGED; CANCER CLASSIFICATION; CANCER GRADING; CANCER MORTALITY; CANCER PATIENT; CANCER REGISTRY; CLINICAL ASSESSMENT; CONFERENCE PAPER; CONTROLLED STUDY; DENMARK; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; DISTANT METASTASIS; ENDOMETRIOID CARCINOMA; ENDOMETRIUM TUMOR; FEMALE; FOLLOW UP; HAZARD RATIO; HIGH GRADE SEROUS CARCINOMA; HISTOPATHOLOGY; HUMAN; LOW GRADE SEROUS CARCINOMA; MAJOR CLINICAL STUDY; MEDICAL EXPERT; OVARIAN SEROUS CARCINOMA; OVARY ADENOCARCINOMA; OVARY CARCINOMA; OVARY TUMOR; OVERALL SURVIVAL; PATHOLOGIST; PATHOPHYSIOLOGY; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SEROUS BORDERLINE OVARIAN TUMOR; SURVIVAL RATE; TUMOR LOCALIZATION; VAGINA CYTOLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CYSTADENOCARCINOMA, SEROUS; DENMARK; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; OVARIAN NEOPLASMS; YOUNG ADULT;

EID: 84861197415     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.02.028     Document Type: Conference Paper

References (39)

1. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J Clin 61 2 Mar 2011 69 90
2. M.A. Roett, and P. Evans Ovarian cancer: an overview Am Fam Physician 80 6 Sep 15 2009 609 616
3. I. Vergote, B.J. De, A. Fyles, K. Bertelsen, N. Einhorn, and P. Sevelda Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma Lancet 357 9251 Jan 20 2001 176 182
4. T. Motohara, H. Tashiro, Y. Miyahara, I. Sakaguchi, H. Ohtake, and H. Katabuchi Long-term oncological outcomes of ovarian serous carcinomas with psammoma bodies: a novel insight into the molecular pathogenesis of ovarian epithelial carcinoma Cancer Sci 101 6 Jun 2010 1550 1556
5. J.D. Seidman, and R.J. Kurman Pathology of ovarian carcinoma Hematol Oncol Clin North Am 17 4 Aug 2003 909 925 vii
6. D.M. Gershenson The heterogeneity of epithelial ovarian cancer: getting it right Cancer 116 6 Mar 15 2010 1400 1402
7. J.D. Seidman, I. Horkayne-Szakaly, J.A. Cosin, H.S. Ryu, M. Haiba, and C.R. Boice Testing of two binary grading systems for FIGO stage III serous carcinoma of the ovary and peritoneum Gynecol Oncol 103 2 Nov 2006 703 708
8. D. Mayr, and J. Diebold Grading of ovarian carcinomas Int J Gynecol Pathol 19 4 Oct 2000 348 353
9. A.R. Blair, and C.M. Casas Gynecologic cancers Prim Care 36 1 Mar 2009 115 130 ix
10. J. Brugghe, J.P. Baak, E. Wiltshaw, M. Brinkhuis, G.A. Meijer, and C. Fisher Quantitative prognostic features in FIGO I ovarian cancer patients without postoperative treatment Gynecol Oncol 68 1 Jan 1998 47 53
11. K. Bertelsen, B. Holund, and E. Andersen Reproducibility and prognostic value of histologic type and grade in early epithelial ovarian cancer Int J Gynecol Cancer 3 2 Mar 1993 72 79
12. P. Sevelda, N. Vavra, M. Schemper, and H. Salzer Prognostic factors for survival in stage I epithelial ovarian carcinoma Cancer 65 10 May 15 1990 2349 2352
13. R.C. Young, L.A. Walton, S.S. Ellenberg, H.D. Homesley, G.D. Wilbanks, and D.G. Decker Adjuvant therapy in stage I and stage II epithelial ovarian cancer. Results of two prospective randomized trials N Engl J Med 322 15 Apr 12 1990 1021 1027
14. K. Bertelsen, B. Holund, J.E. Andersen, K. Nielsen, I. Stroyer, and P. Ladehoff Prognostic factors and adjuvant treatment in early epithelial ovarian cancer Int J Gynecol Cancer 3 4 Jul 1993 211 218
15. E.M. Doyle, M. Foley, P. Kelehan, and E.E. Mooney Histological grading of epithelial ovarian carcinomas J Obstet Gynaecol 27 1 Jan 2007 71 74
16. S. Ishioka, S. Sagae, K. Terasawa, M. Sugimura, Y. Nishioka, and K. Tsukada Comparison of the usefulness between a new universal grading system for epithelial ovarian cancer and the FIGO grading system Gynecol Oncol 89 3 Jun 2003 447 452
17. Y. Sato, T. Shimamoto, S. Amada, Y. Asada, and T. Hayashi Prognostic value of histologic grading of ovarian carcinomas Int J Gynecol Pathol 22 1 Jan 2003 52 56
18. C. Trope, J. Kaern, T. Hogberg, V. Abeler, B. Hagen, and G. Kristensen Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument Ann Oncol 11 3 Mar 2000 281 288
19. K. Sjovall, B. Nilsson, and N. Einhorn Different types of rupture of the tumor capsule and the impact on survival in early ovarian carcinoma Int J Gynecol Cancer 4 5 Sep 1994 333 336
20. A.E. Reles, C. Gee, I. Schellschmidt, A. Schmider, M. Unger, and W. Friedmann Prognostic significance of DNA content and S-phase fraction in epithelial ovarian carcinomas analyzed by image cytometry Gynecol Oncol 71 1 Oct 1998 3 13
21. G.H. Eltabbakh, J.L. Belinson, A.W. Kennedy, C.V. Biscotti, G. Casey, and R.R. Tubbs p53 overexpression is not an independent prognostic factor for patients with primary ovarian epithelial cancer Cancer 80 5 Sep 1 1997 892 898
22. C.B. Finn, J. Dunn, E.J. Buxton, D.M. Luesley, and M. Shafi Can we predict a high risk group in stage I epithelial ovarian cancer? Int J Gynecol Cancer 3 4 Jul 1993 226 230
23. M.S. Carey, A.J. Dembo, J.E. Simm, A.W. Fyles, T. Treger, and R.S. Bush Testing the validity of a prognostic classification in patients with surgically optimal ovarian carcinoma: a 15-year review Int J Gynecol Cancer 3 1 Jan 1993 24 35
24. Y. Shimizu, S. Kamoi, S. Amada, F. Akiyama, and S.G. Silverberg Toward the development of a universal grading system for ovarian epithelial carcinoma: testing of a proposed system in a series of 461 patients with uniform treatment and follow-up Cancer 82 5 Mar 1 1998 893 901
25. Y. Shimizu, S. Kamoi, S. Amada, K. Hasumi, F. Akiyama, and S.G. Silverberg Toward the development of a universal grading system for ovarian epithelial carcinoma. I. Prognostic significance of histopathologic features - problems involved in the architectural grading system Gynecol Oncol 70 1 Jul 1998 2 12
26. A. Malpica, M.T. Deavers, K. Lu, D.C. Bodurka, E.N. Atkinson, and D.M. Gershenson Grading ovarian serous carcinoma using a two-tier system Am J Surg Pathol 28 4 Apr 2004 496 504
27. R. Vang, I. Shih, R. Salani, E. Sugar, A. Ayhan, and R.J. Kurman Subdividing ovarian and peritoneal serous carcinoma into moderately differentiated and poorly differentiated does not have biologic validity based on molecular genetic and in vitro drug resistance data Am J Surg Pathol 32 11 Nov 2008 1667 1674
28. R. Vang, I. Shih, and R.J. Kurman Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems Adv Anat Pathol 16 5 Sep 2009 267 282
29. I. Shih, and R.J. Kurman Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis Am J Pathol 164 5 May 2004 1511 1518
30. R.J. Kurman, and I. Shih Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer-Shifting the paradigm Hum Pathol 42 7 Jul 2011 918 931
31. D.M. Gershenson, C.C. Sun, K.H. Lu, R.L. Coleman, A.K. Sood, and A. Malpica Clinical behavior of stage II-IV low-grade serous carcinoma of the ovary Obstet Gynecol 108 2 Aug 2006 361 368
32. Bodurka DC, Deavers MT, Tian C, Sun CC, Malpica A, Coleman RL, et al. Reclassification of serous ovarian carcinoma by a 2-tier system: A Gynecologic Oncology Group Study. Cancer 2011 Nov 9. [Electronic publication ahead of print].
33. M. Kobel, S.E. Kalloger, J.L. Santos, D.G. Huntsman, C.B. Gilks, and K.D. Swenerton Tumor type and substage predict survival in stage I and II ovarian carcinoma: insights and implications Gynecol Oncol 116 1 Jan 2010 50 56
34. The Danish Pathology Data Bank available in 2011 at http://www.patobank. dk
35. A. Kjaerbye-Thygesen, L.D. Huusom, K. Frederiksen, and S.K. Kjaer Primary ovarian cancer. A comparison of registrations in the Danish Cancer Registry and the Pathology Data Bank Ugeskr Laeger 169 1 Jan 1 2007 50 54
36. The Danish National Board of Health available in 2011 at http://www.sst.dk
37. The Danish Cancer Registry available in 2011 at http://www.sst.dk
38. The Danish Civil Registration System available in 2011 at http://www.cpr.dk
39. J. Permuth-Wey, and T.A. Sellers Epidemiology of ovarian cancer Methods Mol Biol 472 2009 413 437